.webp)
Photo: Bloomberg.com
Since its Nasdaq debut in late 2021, prestige hair care brand Olaplex has faced one of the steepest declines in the beauty sector, losing nearly 95% of its market value. Initially priced at $25 per share, the stock surged to an early high of $29.41 by January 2022, riding strong demand and IPO momentum. But the company quickly encountered a series of setbacks that drove shares below $1.50, leaving it with a market capitalization near $1 billion.
The downward trajectory began with declining sales and regulatory challenges in 2022, but the defining blow came from a 2023 lawsuit involving nearly 30 women who alleged that certain products caused hair loss and damage. The case centered on the ingredient lilial, which Olaplex removed from all products. Though the lawsuit was dismissed, consumer perception and social media criticism lingered, contributing to a 47.8% drop in U.S. net sales and a 74.8% decline in net income for fiscal 2023.
In late 2023, the company brought in CEO Amanda Baldwin, former leader of Supergoop, to spearhead a turnaround. Baldwin has focused on deepening customer engagement, innovating product lines, and reshaping public perception. Her strategy includes launching new bond-building hair treatments, such as the recently released pre-shampoo revitalizer, which represents the next step in Olaplex’s proprietary technology.
Baldwin emphasized that the brand is working to become more approachable without losing its scientific credibility. According to recent brand health tracking, consumers now view Olaplex as “more alluring and approachable,” while retaining its reputation as an iconic, science-driven brand.
Olaplex faces intensified competition from brands like K18, Ouai, and Redken, which have capitalized on gaps in the market during Olaplex’s struggles. Analysts from JPMorgan Chase maintain a cautious stance, citing “a challenging operating backdrop, stressed consumers, and strong competitors” as headwinds likely to persist in the near term.
Despite these challenges, analysts like Susan Anderson see positive signs: sales stabilization, ongoing product innovation, and diminished impact from past lawsuits indicate potential for recovery. Hair and scalp health remains a high-growth area within beauty, providing opportunities for Olaplex to expand its influence and capture new customers.
Olaplex’s fourth-quarter report for 2025 showed a modest 4.3% increase in net sales to $105.1 million compared to Q4 2024, while full-year sales grew just 0.1%. Shares fell more than 20% following the report.
The company has also attracted potential acquisition interest. In January, reports surfaced that Germany-based Henkel considered acquiring Olaplex, driving the stock up over 30% amid speculation. While the company did not confirm the offer, analysts note that Olaplex’s loyal consumer base and strong brand identity make it an appealing takeover target.
Olaplex’s path to recovery hinges on sustaining product innovation, rebuilding consumer trust, and differentiating itself in a crowded market. With bond-building technology at the heart of its offerings and new treatments aimed at revitalizing hair health, the brand is positioning itself to reclaim prestige status in the hair care sector.
As Baldwin noted, Olaplex remains committed to creating products that combine science, performance, and approachability, signaling the brand’s intent to recover both market share and investor confidence in the months ahead.









